Search for: "Endo Pharmaceuticals Holdings Incorporated" Results 1 - 10 of 10
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 May 2015, 1:14 pm
  Here, for instance, is what the court said about the City’s claims under its municipal codes against the Endo Pharmaceuticals defendants:   [T]he City does not explain what editorial control, if any, the Endo entities had over materials they allegedly sponsored or funded. [read post]
18 Aug 2022, 1:40 pm by Kevin LaCroix
  Background Endo is a pharmaceutical company incorporated in Ireland but based in Pennsylvania. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
14 Jul 2011, 8:40 pm
(now part of Pennsylvania-based Endo Pharmaceuticals) and Coloplast. [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
Cordis Corporation, et al., No. 15-998 (follow-on to SCA) Safe Harbor: Amphastar Pharmaceuticals, Inc., et al. v. [read post]
18 May 2016, 8:19 am by Dennis Crouch
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
 The original Federal Circuit opinion cited to Teva, but not for its holding regarding deference. [read post]
9 Dec 2020, 2:13 pm by Kevin LaCroix
In this case, CBS’s proxy statements from 2016 to 2018 incorporated the Company’s Business Conduct Statement which sets forth the ethical conduct expected of all directors and employees. [read post]
28 Jun 2016, 6:41 am by Dennis Crouch
 A major caveat of this appealability issue is that the court limited its holding to run-of-the-mill IPR patent issues. [read post]